MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence

Autor: Qiaoting Hu, Mengxian Tu, Xinyi Wang, Mingyu Liu, Rongcheng Luo, Zike Yang, Guoxiong Yang
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Adult
0301 basic medicine
Cancer Research
Carcinoma
Hepatocellular
Epithelial-Mesenchymal Transition
Cirrhosis
Survival
MAP Kinase Signaling System
Gene Expression
lcsh:RC254-282
Metastasis
03 medical and health sciences
0302 clinical medicine
Recurrence
In vivo
Cell Line
Tumor
Biomarkers
Tumor
Hepatectomy
Humans
Medicine
Aged
Neoplasm Staging
Proportional Hazards Models
Gene knockdown
business.industry
Cell growth
MEK/ERK pathway
Research
Liver Neoplasms
EMT
Middle Aged
Prognosis
medicine.disease
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Immunohistochemistry
Minichromosome maintenance complex component 6
Treatment Outcome
030104 developmental biology
ROC Curve
Oncology
Apoptosis
Gene Knockdown Techniques
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Cancer research
Neoplasm Grading
business
Zdroj: Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-13 (2018)
Journal of Experimental & Clinical Cancer Research : CR
ISSN: 1756-9966
DOI: 10.1186/s13046-017-0669-z
Popis: Background The high incidence of recurrence and metastasis of hepatocellular carcinoma (HCC) necessitate the discovery of new predictive biomarkers of invasion and prognosis. Minichromosome maintenance complex component 6 (MCM6), which has been reported to up-regulate in multiple malignancies, was considered to be a novel diagnoses biomarker in HCC. However, its functional contributions and prognostic value remain unclear. Methods The expression of MCM6 was analyzed in 70 HCC tissues and 5 HCC cell lines by immunohistochemistry and real-time RT-PCR. The roles of MCM6 in HCC cell proliferation, migration and invasion were explored by CCK8, Wound healing and Transwell assays, respectively. Western blotting and Immunofluorescence staining were conducted to detect the protein expressions of ERK signaling pathway and EMT-related markers. To verify the above findings in vivo, we established subcutaneous xenograft tumor and orthotopic xenograft tumor models in nude mice. Finally, Enzyme-linked immunosorbent assay was used to evaluate the serum MCM6 level. Results MCM6 was significantly up-regulated in HCC tissues. Increased MCM6 expression was associated with aggressive clinicopathological features and worse prognosis in HCC patients. These results were consistent with our analyses of The Cancer Genome Atlas database (TCGA). Furthermore, knockdown of MCM6 significantly decreased proliferative and migratory/invasive capability of HCC cells in vitro, as well as decreased tumor volume, weight and the number of pulmonary metastases in vivo. Mechanistic analyses indicated that MCM6 promoted EMT and activated MEK/ERK signaling. More importantly, serum MCM6 levels in HCC patients were significantly higher than those in cirrhosis and healthy controls (P
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje